Allergy Escape

Euphrasia Officinalis, Kali Muriaticum, Natrum Muriaticum, Sabadilla, Wyethia Helenoides, Kali Iodatum, Naphthalinum, Histaminum Hydrochloricum


Ratis, Llc
Human Otc Drug
NDC 71753-2010
Allergy Escape also known as Euphrasia Officinalis, Kali Muriaticum, Natrum Muriaticum, Sabadilla, Wyethia Helenoides, Kali Iodatum, Naphthalinum, Histaminum Hydrochloricum is a human otc drug labeled by 'Ratis, Llc'. National Drug Code (NDC) number for Allergy Escape is 71753-2010. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Allergy Escape drug includes Euphrasia Stricta - 6 [hp_X]/mL Histamine Dihydrochloride - 9 [hp_C]/mL Naphthalene - 9 [hp_X]/mL Potassium Chloride - 6 [hp_X]/mL Potassium Iodide - 9 [hp_X]/mL Schoenocaulon Officinale Seed - 6 [hp_X]/mL Sodium Chloride - 6 [hp_X]/mL Wyethia Helenioides Root - 8 [hp_X]/mL . The currest status of Allergy Escape drug is Active.

Drug Information:

Drug NDC: 71753-2010
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Allergy Escape
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Euphrasia Officinalis, Kali Muriaticum, Natrum Muriaticum, Sabadilla, Wyethia Helenoides, Kali Iodatum, Naphthalinum, Histaminum Hydrochloricum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Ratis, Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:EUPHRASIA STRICTA - 6 [hp_X]/mL
HISTAMINE DIHYDROCHLORIDE - 9 [hp_C]/mL
NAPHTHALENE - 9 [hp_X]/mL
POTASSIUM CHLORIDE - 6 [hp_X]/mL
POTASSIUM IODIDE - 9 [hp_X]/mL
SCHOENOCAULON OFFICINALE SEED - 6 [hp_X]/mL
SODIUM CHLORIDE - 6 [hp_X]/mL
WYETHIA HELENIOIDES ROOT - 8 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 21 Mar, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 19 Apr, 2023
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 14 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Ratis, LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:C9642I91WL
3POA0Q644U
2166IN72UN
660YQ98I10
1C4QK22F9J
6NAF1689IO
451W47IQ8X
J10PD1AQ0N
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class:Increased Large Intestinal Motility [PE]
Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
Osmotic Activity [MoA]
Osmotic Laxative [EPC]
Potassium Compounds [CS]
Potassium Salt [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
71753-2010-130 mL in 1 BOTTLE, SPRAY (71753-2010-1)21 Mar, 201819 Apr, 2023No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses: temporarily relieves seasonal and environmental allergies such as runny nose, itchy eyes, sinus pressure, and puffy skin.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

Product Elements:

Allergy escape euphrasia officinalis, kali muriaticum, natrum muriaticum, sabadilla, wyethia helenoides, kali iodatum, naphthalinum, histaminum hydrochloricum euphrasia stricta euphrasia stricta potassium chloride potassium cation sodium chloride chloride ion schoenocaulon officinale seed schoenocaulon officinale seed wyethia helenioides root wyethia helenioides root potassium iodide iodide ion naphthalene naphthalene histamine dihydrochloride histamine water alcohol glycerin

Indications and Usage:

Indications: temporarily relieves seasonal and environmental allergies such as runny nose, itchy eyes, sinus pressure, and puffy skin.** **these statements are based upon traditional homeopathic practice. they have not been reviewed by the food and drug administration.

Warnings:

Warnings: for oral use only. if pregnant or breast-feeding, or if symptoms persist or worsen or worsen, ask a health care professional. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away. do not use if tamper evident seal is broken or missing.

Dosage and Administration:

Directions: adults: 2 sprays 3 times a day or as needed. children 1-12: 1 spray as needed.

Package Label Principal Display Panel:

Package label display: ndc 71753-2010-1 anna's remedies allergy escape formulated by miranda castro homeopathic oral spray 1 fl. oz (30ml) allergy escape

Further Questions:

Questions: comments? visit homeopathystore.com or call (888) 405-7551. distributed by: ratis, llc, 211 e. lombard st, ste 303, baltimore, md 21202


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.